Clinical Trials Logo

Clinical Trial Summary

Third molar extraction is one of the most performed surgical procedures in Dentistry. A comfortable postoperative period and rapid return to daily activities increase the need to control the inflammatory response and its signs and symptoms such as pain, edema, and lockjaw. Therefore, the objective of this study is to evaluate the efficacy of the prophylactic use of Photobiomodulation in the reduction of edema in the postoperative period of extractions of retained lower third molars.The primary study variable will be postoperative edema measured in millimeters, 48 hours after surgery, and the secondary variables will be: pain, lockjaw, local temperature (measured with a thermographic camera), dysphagia, and the need to ingest nonsteroidal analgesics (Acetaminophen)These variables will be evaluated at the beginning of the study (baseline), at 2 and 7 days post-surgery. All adverse effects will be recorded. The data obtained will be represented by their means ± SD and the p value will be set at 0.05.


Clinical Trial Description

Third molar extraction is one of the most performed surgical procedures in Dentistry. A comfortable postoperative period and rapid return to daily activities increase the need to control the inflammatory response and its signs and symptoms such as pain, edema, and lockjaw. To control these events, the prophylactic use of anti-inflammatory steroids has been widely recommended by some authors. However, there is no strong evidence on the real benefits of its use as opposed to its possible side effects. Photobiomodulation has proven to be a good alternative when applied in the postoperative period to control pain, edema and lockjaw. On the contrary, its application prior to a procedure of this type has not been sufficiently evaluated. Therefore, the objective of this study is to evaluate the efficacy of the prophylactic use of Photobiomodulation in the reduction of edema in the postoperative period of extractions of retained lower third molars. Healthy individuals (ASA I), who have an indication for extraction and are included in the study, will be randomly divided into two groups: Control Group: with the administration of prophylactic Corticosteroid (Dexamethasone 8 mg/ 1h before surgery), and the simulated application of Photobiomodulation, under the same protocol as the Study Group and Study Group: to which Photobiomodulation will be applied by means of intraoral Low Intensity Laser with wavelengths of 660nm and 808nm applied at 4 anatomical points (power of 0.1W, radiant exposure of 1,061 J/cm2 and energy of 3J per point and an application time of 30 seconds, totaling 12J of energy). Besides, the extraoral application will be carried out with a cluster device of combined LEDs with a total exposure area of 20cm2, which will be composed of 5 LEDs with a wavelength of 630nm (power of 0.25W per LED, a radiant exposure of 3 J /cm2 and energy of 12 J per LED spot, with an exposure time of 48 seconds) and 4 LEDs with a wavelength of 850 nm (power of 0.3W per LED, a radiant exposure of 2.4 J/cm2 and an energy of 12J per LED point, and an exposure time of 40 seconds). The Study Group will be administered a placebo tablet simulating Dexamethasone, also 1 h before the surgical procedure. The primary study variable will be postoperative edema measured in millimeters, 48 hours after surgery, and the secondary variables will be: pain, lockjaw, local temperature (measured with a thermographic camera), dysphagia, and the need to ingest nonsteroidal analgesics (Acetaminophen) after the first 3 postoperative days, where Ketorolac 10 mg will be administered orally, in a regulated manner. These variables will be evaluated at the beginning of the study (baseline), at 2 and 7 days post-surgery. All adverse effects will be recorded. The data obtained will be represented by their means ± SD and the p value will be set at 0.05. Keywords: photobiomodulation, corticosteroids, extraction, edema, pain, lockjaw, quality of life, randomized controlled trial. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05924191
Study type Interventional
Source University of Nove de Julho
Contact
Status Not yet recruiting
Phase N/A
Start date November 30, 2023
Completion date July 8, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05722509 - Evaluation of a New Technique for Periodontal Pocket Reduction in the Extraction of Wisdom Teeth N/A
Completed NCT05992233 - "Effectiveness of Dual-Wavelength Laser Therapy in Third Molar Extraction Pain, Swelling, and Trismus" N/A
Withdrawn NCT05374993 - An Early Feasibility Evaluation of a Novel 3rdMolarTooth Bud Ablation Procedure N/A
Recruiting NCT05923775 - Pain and Trismus Control in Third Molar Surgery: Ibuprofen, Ketamine, and Their Combination N/A
Completed NCT04182191 - Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam Phase 4
Completed NCT04203771 - Probiotic Intervention After Surgical Removal of Mandibular Third Molars N/A
Recruiting NCT05941130 - 3D Evaluation of Postoperative Edema After Third Molar Surgery Phase 4
Completed NCT04033744 - Prevention of Mandibular Third Molar Extraction- Associated Periodontal Defects Using Platelet-Rich Fibrin N/A
Completed NCT00154518 - The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement Phase 1
Active, not recruiting NCT06073535 - The Use of Injectable-Platelet Rich Fibrin (i-PRF) in the Lower Third Molar Extraction N/A
Completed NCT02890680 - Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery N/A
Completed NCT03545022 - Acupuncture on Anxiety and Inflammatory Events Following Surgery of Mandibular Third Molars N/A
Recruiting NCT02284841 - Effect of Hilotherm Therapy on Post-operative Pain and Swelling Following Surgical Wisdom Tooth Removal N/A
Recruiting NCT01896427 - Comparing Pain and Swelling After Surgical Extraction of Mandibular Third Molar in Dexamethasone Injection and Without Corticosteroid Methods Phase 4
Enrolling by invitation NCT03567369 - 92/5000 Preoperative Efficacy of Traumeel Versus Dexamethasone in the Control of Pain, Swelling and Trismus N/A